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ABSTRACT

THE EFFECT OF HEARING AID USE ON COGNITION IN OLDER ADULTS
WITH ADULT ONSET HEARING LOSS: A SYSTEMATIC REVIEW
By
JONA CANO

Advisor: Carol Silverman, Ph. D., M.P.H

The goal of this paper was to systematically review literature in order to investigate
whether the use of amplification in the form of hearing aids by older adults positively impacts
cognitive status. If the results of this review uncover a positive association between hearing-aid
use and cognition, then hearing aids can be recommended as an intervention method for the
mitigation of cognitive decline. The eight studies included in this paper were reviewed based on
the research design and the cognitive outcome measures employed. Additionally, the secondary
measures of health utilized by study investigators were also evaluated. Of the eight studies
reviewed, four showed a positive association between amplification and cognition, one showed a
negative association between amplification and cognition, and three showed that cognitive status
is unchanged by amplification use. Although the studies did not unequivocally support the use of
hearing aids as an intervention method for cognitive decline in older adults with hearing loss, no
evidence in these studies exists to indicate any detrimental effect of amplification use. Thus,
audiologists should continue to recommend hearing aids to older adults with hearing loss as they
can improve quality of life and also may contribute to cognitive health.
Key Words: “cognition,” “hearing loss,” “amplification,” “hearing aid,” and “adult.
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INTRODUCTION
Hearing loss is a growing health condition in older adults, recently becoming the third
most common disorder in the United States. Approximately 61% of adults ages 70 years and
older have a disabling hearing loss as defined by the World Health Organization (Lin et al.,
2011a; WHO 2017). This prevalence only increases with age, as indicated by an approximate
78% prevalence of hearing loss in adults between the ages of 80 and 84 years and 80%
prevalence in adults who are 85 years and older. Hearing loss can result in difficulty with
communication and untreated hearing loss is associated with increased hearing handicap, social
isolation, and depressive symptoms (Dalton et al., 2003; Gopinath et al., 2009; Weinstein &
Ventry, 1982). Additionally, untreated hearing loss is independently associated with a 30-40%
rate of accelerated cognitive decline as well as with general cognitive impairment (Lin et al.,
2013) and a higher incidence of dementia (Lin et al., 2011b, Lin et al., 2013; Uhlmann et al.,
1989;). The increased risk of developing dementia is correlated with severity of hearing loss.
Compared with individuals having normal-hearing sensitivity, those with a mild, moderate, and
severe hearing loss are 2,3, and 5 times more likely to develop dementia, respectively (Lin et. al.,
2013).
As of 2010, the number of individuals over the age of 65 years with dementia was
estimated to be 4.7 million. This number is expected to grow to 13.8 million by 2050 (Hebert et
al., 2013). The health spending associated with the disease was estimated at $818 billion in 2015
and is expected to grow to $2 trillion by 2030 (Prince et al., 2015). Management of the disease
and the need to reduce health care spending is important, making the management of dementia a
public health priority. Pharmacological approaches to managing dementia have proven to be

1

ineffective; thus, addressing risk factors for dementia may be a more effective approach to
addressing the public health concern. A 10%-25% decrease in risk factors is estimated to
potentially result in a reduction of as many as 492,000 individuals with Alzheimer’s disease in
the United States alone (Barnes & Yaffe, 2011). As hearing loss has been implicated as a risk
factor for dementia and cognitive decline, audiologists need to become one of the
multidisciplinary allies to treat the growing affected population.
This systematic review was conducted to investigate whether the use of amplification in
the form of hearing aids in older adults with hearing loss has a positive impact on cognitive
status. If so, amplification through hearing aids could serve as a form of intervention to minimize
or forestall cognitive decline.
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METHODS
The search words were selected a priori as a way to include the maximum number of
studies that are relevant to measures of cognitive status in older adults with hearing loss who
utilize hearing aids. Search words in the PubMed database included “cognition,” “hearing loss,”
“amplification,” “hearing aid,” and “adult.” This initially yielded 46 studies. Studies were
excluded if they included cochlear implantation as a method of amplification or included
pediatric participants, which excluded 17 studies. Of the remaining 29 studies, 10 more studies
were excluded because amplification included use of personal sound amplifiers and
osseointegrated implantable hearing aids (Baha). Of the remaining 19 studies, one could not be
found translated in English from the original German and 10 were irrelevant as they did not
directly measure cognition. Furthermore, existing literature reviews were also excluded. The
application of these exclusion criteria resulted in the 8 studies reviewed in this paper.
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RESULTS
Outcome Measures
The study characteristics and demographics, including the population sample, mean age,
gender makeup, dependent variables (outcome measures), and the independent variable (degree
of hearing loss), for all eight studies are displayed in Table 1.
All studies in this review included an outcome measure that assessed cognitive status.
The most commonly employed measure of cognitive status was the Mini Mental State
Examination (MMSE). The MMSE is a screening tool that can be used by audiologists and other
professionals for identifying dementia. Although the MMSE alone cannot be used to diagnose a
cognitive deficit, it can be utilized as a method of quantifying and estimating cognitive decline.
Typically, a cut-off score of 24 (out of a maximum score of 30) is used as a criterion for
identifying cognitive decline (Folstein et al., 1975; Tombaugh et al., 1992). The MMSE often is
utilized due to its ease of use and its fast administration time. It also exhibits excellent sensitivity
(99%) and good specificity (86%) for identifying moderate to severe dementia. Because of its
lesser sensitivity to mild cognitive impairment, it should be utilized to screen only for significant,
moderate or worse cognitive impairment (Tombaugh et al., 1992).
Other measures of cognitive status utilized in the studies can be classified within three
general categories: working memory tests, selective attention tests, and processing speed tests.
Tests of working memory include the Listening Span Test (LST), Reading Span Test (RST), and
Visual Verbal Learning Test (VVLT). Selective attention tests include Coordinate Response
Measure (CRM) and Stroop Color Word Test (SCWT). Processing speed tests include Trail
Making Test (TMT), Digit Symbol Substitution Test (DSST), Auditory Reaction Time, Auditory
Verbal Learning Test (AVLT), Verbal Fluency Test (VFT), Mental Component Score (MCS),
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Concept Shifting Task (CST), Letter Digit Substitution Test (LDST). These assessments are
domain specific. Using a battery comprising an assessment from each category enables one to
more comprehensively describe cognitive status.
Other outcome measurements were employed to assess other aspects of health. Hearing
handicap was assessed with the Hearing Handicap Inventory for the Elderly (HHIE) and physical
health was assessed with the Physical Component Score (PCS). Psychiatric/depressive symptoms
were assessed with the Geriatric Depression Scale (GDS), the MOUSEPAD and the Cornell
Scale for Depression in Dementia. Limitations in Instrumental Activities for Daily Living
(IADL) were assessed with the Instrumental Deterioration for Daily Living in Dementia (IDDD)
as well as Nursing Home Hearing Handicap Index for Patient and Caretaker (NHHHIP and
NHHHIC). Activities of Daily Living (ADL) were also assessed. These differ from IADL as
ADLs refer to more basic activities (e.g. feeding, bathing, dressing, etc) whereas IADLs refer to
more complex tasks (financial management, shopping, medication management, etc). Caregiver
burden was assessed with the Carer Strain Scale and Carer Burden scale. Social engagement was
also evaluated by asking patients their self-reported perceptions of how often they participate in
solitary activities.
Study Characteristics Summary
Table 2 displays study characteristics and study design, including the type of the hearing
loss, cognitive status prior to amplification, socioeconomic status of participants, research
design, control group status, and follow-up period for all eight studies. As displayed in Table 2,
the studies included in this systematic review were prospective studies that were either withinsubject designs or mixed subject designs. Of the eight studies, four (50%) had within-subject
designs and the remaining four (50%) had mixed study designs. In the latter studies, at least two
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experimental groups (HA users and non-users) were followed over time. The within-subject
design studies include Acar, Yurekli, Babademez, Karabulut, and Karasen (2011), Allen et al.
(2003), Desjardins (2015), and Dawes et al. (2015a). Of these four studies, control groups were
lacking in two (50%) of these four studies (Acar et al., Allen et al.), as all participants received
amplification and were first-time hearing-aid users. As shown in Table 2, the follow-up period
was 3 months for Acar et al. and 6 months for Allen et al. Desjardins, whose 6 participants
received amplification for a duration of 6 months, also included a withdrawal phase whereby
participants were retested after two weeks of discontinued hearing-aid use (see Table 1). The
within-subject design studies had smaller samples as compared to the mixed study design
studies, with the exception of Dawes et al. whose sample size was much larger (164,770). As
shown in Table 1, the within-subject design studies differed from each other with respect to
participant age. Of the four within-subject design studies, 50% (Acar et al.; Allen et al.) were
done on elderly subjects with reported mean ages of 70.8 and 84.0 years, respectively. Desjardins
and Dawes et al. included middle-aged and older adults ages 40 to 69 years. Table 1 also
indicates that the hearing loss was at least moderate in degree in at least one ear for two of the
four studies (Acar et al.; Allen et al.) but was milder in the other two studies (Desjardins; Dawes
et al.). Table 2 shows the nature of hearing loss reported by Acar et al. and Desjardins was
sensorineural and symmetrical, consistent with a presbycusis audiometric configuration. Allen et
al. and Dawes et al. did not report the configuration of hearing loss of their participants. Neither
Acar et al. nor Allen et al. reported the socioeconomic status of the participants whereas Dawes
et al. and Desjardins both reported the mean socioeconomic of their participants.
The cognitive status of the participants at the start of the study varies among the withinsubject studies. As shown in Table 2, Acar et al. (2005) did not describe the cognitive status of
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their participants prior to study participation. In Allen et al.’s (2003) investigation, all
participants previously had been diagnosed with primary dementia according to the criteria set
forth by DSM IV. In contrast, in Desjardins’ (2015) investigation, all participants passed the
Mental Health Status Questionnaire; a pass result on that questionnaire rules out a cognitive
impairment. This difference in how Acar et al. and Desjardins approach cognitive status preintervention is important to note when analyzing and comparing study findings.
The mixed design studies include Amieva et al. (2016), Dawes et al. (2015b), Valentijn et
al. (2005), and Van Hooren et al. (2004). In these four studies, at least two groups of older
individuals with hearing loss were evaluated: an experimental group of first-time hearing-aid
users and a control group comprising non-users of hearing-aids who had follow-up periods
ranging from one to twenty-five years. Amieva et al. also included an additional control group
with no reported hearing loss. As shown in Table 1, the sample sizes of these four studies ranged
from 102 to 3,670 with a mean age ranging from 65.9 to 81.7 years. The female-to-male ratio
favored female participants in the Amieva et al. and Dawes et al. studies and favored male
participants in the Valentijn et al. and Van Hooren et al. studies.
Hearing loss was established either as an independent variable or as a constant in these
four mixed design studies. Amieva et al. (2016) grouped participants based on self-reported
hearing loss as follows: those with no hearing loss, those with moderate hearing loss, and those
with major hearing loss. Of the 1,276 participants who reported hearing loss, 150 (11.8%) were
users of hearing aids and 1,126 (88.2%) were non-users of hearing aids. Thus, the 25-year study
involved two independent variables, hearing loss and hearing-aid use. Table 1 indicates the
participants in the Dawes et al., Valentijn et al., and Van Hooren et al. studies all had at least a
moderate hearing loss in at least one ear. The degree of hearing loss was similar between the
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experimental and control groups in the Van Hooren et al. study but was worse in the group of
users of hearing-aids than in the group of non-users of hearing aids in the Dawes et al. and
Valentijn et al. studies.
Table 2 demonstrates that the demographic variable of socioeconomic status was
controlled in all four mixed design studies. In three of the four studies (Amieva et al., 2016;
Valentijn et al., 2005; Van Hooren et al., 2004), the investigators defined socioeconomic status
based on education level that is, all participants had at least primary school education. Dawes et
al. (2015b) defined socioeconomic status in terms of yearly salary, which was low, less than
$45,000 in 80% of participants, for both the control and experimental groups. Neither Amieva et
al. nor Dawes et al. assessed cognitive status of participants prior to baseline testing. On the
other hand, Valentijn et al. and Van Hooren et al. ruled out significant cognitive impairment
prior to baseline testing.
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Table 1
Study Characteristics and Demographics

Author

(n)

Age (Years)
Mean (SD)

Gender
F:M

Dependent
Variables

Independent Variable:
Hearing Loss

Acar et al.
(2011)

34

70.8 (4.8)

4 : 30

Cognitive status
(MMSE)1

PTA ≥ 40 dB HL .5k4kHz in better ear

Depressive Symptoms
(GDS)2

Average PTA 57.2 dB
HL Right ear, 56.3 dB
HL left ear

Cognitive status (MMSE)

PTA ≥ 40 dB HL .5k4kHz in better ear

Allen et al.
(2003)

31

84 (6.6)

25 : 6

9

Psychiatric symptoms
(MOUSEPAD, Cornell
scale)

Average PTA Better ear
59.32 db HL

IADL (IDDD)3
Caregiver burden (The
Carer Strain Scale, Carer
Burden)

Amieva et al.
(2016)

1

Total: 3,670

Mini Mental State Examination
Geriatric Depression Scale
3 Instrumental Deterioration for Daily Living in Dementia
2

Cognitive status (MMSE)

Self-reported Moderate
HL

Author

Dawes et. al.
(Mar 2015)

(n)

Age (Years)
Mean (SD)

Gender
F:M

Dependent
Variables

Major HL:
137

81.7 (7.7)

67 : 70

4%
Major HL

Moderate HL:
1,139

76.7 (7.0)

564 : 575

31%
Moderate HL

No HL:
2,394

73.8 (6.2)

1,499 : 895

65%
No HL

164,770

Range: 40-69

54.5% : 45.5%

Reaction Time
Pairs matching
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Fluid Intelligence

Independent Variable:
Hearing Loss

Digit Triplet Test (DDT)

Author

(n)

Age (Years)
Mean (SD)

Gender
F:M

Dependent
Variables

Independent Variable:
Hearing Loss

Dawes et. al.
(Nov 2015)

666

Total range:
48-92

N/A

Cognitive performance
(MMSE, TMT4, DSST5,
AVLT6, VFT7)

Average threshold 3k4kHz >40 dB HL in
better ear

Handicap (HHIE)8
Physical Health (PCS)9
Emotional Health
(MCS)10
Social engagement
ADL and IADL

11
4

HA User:
69

HA User:
69.5 (9.8)

HA User:
22:47

HA user:
PTA 38.9

Non-User:
597

Non-User:
68.0 (9.7)

Non-User:
137:460

Non-User:
29.8

Trail Making Test
Digit Symbol Substitution Test
6 Auditory Verbal Learning Test
7 Verbal Fluency Test
8 Hearing Handicap Inventory for the Elderly-Screener
9 Physical Component Score
10 Mental Component Score
5

Author

(n)

Age (Years)
Mean (SD)

Gender
F:M

Dependent
Variables

Independent Variable:
Hearing Loss

Desjardin
(2015)

6

Range: 54-64

N/A

Cognitive function:

High Frequency PTA
(dB HL) of all
participants

Working memory
(LST11, RST12)
Selective attention
(CRM13, SCWT14)
Processing speed
(Auditory Reaction
Time, DSST15)

12
11

Listening Span Test
Reading Span Test
13 Coordinate Response Measure
14 Stroop Color Word Test
15 Digit Symbol Substitution Test
12

S1: 20 dB
S2: 37 dB
S3: 53 dB
S4: 43 dB
S5: 23 dB
S6: 40 dB

Author

(n)

Age (Years)
Mean (SD)

Gender
F:M

Dependent
Variables

Independent Variable:
Hearing Loss

Valentijn et al.
(2005)

418 at start

65.9 (6.7)

204 : 214

Cognitive function:

Average dB HL at 1k,
2k, and 4kHz

391 at 6 year
follow up

Range: 55-83

Recall (VVLT)16

69.6

Selective attention
(SCWT)

Baseline: 16.0 (11.4) dB

HA Users: 7
N/A

13

Van Hooren et
al.
(2004)

HA Nonusers: 384

Processing Speed
(CST17, LDST18)

Total: 102

Cognition:
Processing speed (CST-I,
LDST)
Selective Attention
(SCWT)
Recall Memory (VFT,
VVLT)

16

Visual Verbal Learning Test
Concept Shifting Task
18 Letter Digit Substitution Test
17

Avg PTA for HA Users
at 6yrs : 56.11 (3.90)
Avg PTA for all at 6yrs:
29.2 (14.9)

All participants: at least
35 dB HL PTA at 1k, 2k,
and 4kHz

Author

(n)

Age (Years)
Mean (SD)

Gender
F:M

Dependent
Variables

Independent Variable:
Hearing Loss

HA users:
56

HA Users:
72.54 (7.3)

HA Users:
35.7% : 64.3%

HA Users:
46.46 (-7.3)

Non-Users:
46

Non-Users:
74.5 (6.77)

Non-Users:
37% : 63%

Non-Users:
44.09 (7.69)
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Table 2
Study Characteristics and Design

Author

Participant
Hearing loss

Acar et al.
(2011)

Sensorineural
or mixed

Known
Cognitive
Status
N/A

Socio-Economic
Status/
Education Level
N/A

Research
Design
Within subject
design

Presence of
Control
Group
No

All HA users
were first time
users

Prospective

Allen et al.
(2003)

N/A

15
Amieva et al.
(2016)

Self-reported

Previously
diagnosed
with primary
dementia
(according
DSM IV
criteria)
N/A

N/A

Within subject
design

No

Mixed subject
design
Prospective

6 months
All HA users
were first time
users

Prospective

(N) Acquired
primary school
certificate

Follow Up/
Duration of
HA use
3 months

Yes
Those with no
hearing loss

25 year follow
up
All HA users
were first time
users

Author

Participant
Hearing loss

Known
Cognitive
Status

Socio-Economic
Status/
Education Level
73 (Major HL)

Research
Design

Presence of
Control
Group

Follow Up/
Duration of
HA use

No

N/A

703 (Moderate
HL)
1,617 (No HL)
Dawes et. al.
(Mar 2015)

N/A

N/A

16
Dawes et. al.
(Nov 2015)

Percentage of
people who
had:
Symmetrical
HL: 94.8%
Conductive
HL: 8.1%
Adult Onset:
98.1%

N/A

Score on
Townsend
Deprivation Score:
-1.1

Within subject
design

No significant
differences in
income between
groups

Mixed subject
design

HA user:
<$45,000= 84.5%
Non-User:
<$45,000= 82.3%

Correlational
study

Prospective

Yes

11 years

HA non-users

All HA users
were first time
users

Author
Desjardin
(2015)

Participant
Hearing loss
Bilateral
Symmetrical
Sensorineural
Adult onset

Known
Cognitive
Status
Previously
passed
Portable
Mental Health
Status
Questionnaire
(no known
cognitive
impairment)

Socio-Economic
Status/
Education Level
Average of 18
years of education
(SD 2.5)

Normal
cognition prebaseline

3.0 (1.8)

Research
Design
Single subject
design
Prospective

100% full time
employment

Presence of
Control
Group
Yes
Withdrawal
phase was
measured
when hearing
aid use was
discontinued

Follow Up/
Duration of
HA use
24 weeks of
treatment with
HA
2 weeks of
withdrawal of
HA
All HA users
were first time
users

17
Valentijn et al.
(2005)

N/A

Mean score of
27.8 (1.82) on
MMSE

19

Based on
Hierarchical
scale19

Mixed subject
design

Yes

6 years

HA non-users
Prospective

Hierarchical scale is as follows:
1: primary education 2: lower vocational 3: intermediate secondary 4: intermediate vocational 5: higher general secondary 6: higher vocational education 7:
higher professional education 8: university

Author
Van Hooren et
al.
(2004)

Participant
Hearing loss
Sensorineural
Hearing Loss

18

Known
Cognitive
Status
At least a
score of 24 on
MMSE (no
significant
cognitive
impairment)

Socio-Economic
Status/
Education Level
Education level
based on above
hierarchical scale

No major
psychiatric
and
neurological
disorders

Non-Users:
3.17 (2.08)

Research
Design
Mixed subject
design
Prospective

HA Users:
3.16 (1.96)

Presence of
Control
Group
Yes

Follow Up/
Duration of
HA use
12 months

HA Non-users

All hearing aid
users were
first time
users.

Outcome Summary
The results of the cognitive measures (primary outcome measures) are presented in Table
3. The results of studies that had secondary outcome measures are presented in Table 4. Of the
eight studies reviewed, four (50%) showed a positive association between amplification and
cognition, one (12.5%) showed a negative association between amplification and cognition, and
three (37.5%) showed that cognitive status remains unchanged with amplification. The four
studies that showed a positive association include Acar et al. (2011), Amieva et al. (2016),
Dawes et al. (2015a), and Desjardins (2015). As shown in Table 3, Acar et al. and Desjardins
found a statistically significant improvement in MMSE scores after a 3-month and 6-month
follow-up period, respectively. In Acar et al., amplification benefit also was shown on the GDS,
a secondary outcome measure presented in Table 4, as evidenced by a statistically significant
decrease in depressive symptoms after 3 months of hearing-aid use. Desjardins found that at least
some participants demonstrated improvement on all outcome measurement scores after utilizing
hearing aids for 6 months; the majority of participants demonstrated improvement in LST, CRM,
RST, DSST, reflecting improvement in working memory, selective attention, and processing
speed (see Table 3). The results from Amieva et al., displayed in Table 3, indicate that the rate of
cognitive decline over the 25-year follow-up period in those with hearing loss who did not utilize
hearing aids is higher than that in individuals with normal-hearing sensitivity; the rate of
cognitive decline in those who utilized hearing aids is comparable to that in individuals with
normal-hearing sensitivity. These findings suggest that hearing-aid use can mitigate the rate of
cognitive decline in those with hearing loss. However, when the analysis was adjusted for
depression and social engagement, this difference between the groups no longer was statistically
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significant, indicating that the mitigation of cognitive decline in amplified individuals is
mediated by depression and social isolation. Similarly, the findings of Dawes et al., displayed in
Table 3, reveal that although hearing loss is independently associated with worse cognition,
hearing-aid use is associated with better cognition. This relationship is mediated by social
isolation as increased social isolation is associated with increased depression and worse cognitive
status (see Table 4).
Only one study demonstrated that hearing-aid use is associated with a decline in
cognition. In that study (Allen et al., 2003), the participants, who all used hearing aids,
demonstrated a slight, although significant decrease in MMSE scores (mean decline of 2 points)
after a 6-month follow-up period, as demonstrated in Table 3. The results on secondary outcome
measures, displayed in Table 4, indicated no improvement in activities of daily living, depressive
symptoms, or caregiver burden. The only improvement with amplification that was obtained was
on hearing handicap as reported by both the patient and the caregiver.
The findings of three investigations (Dawes et al., 2015b; Valentijn et al., 2005; Van
Hooren et al., 2004) failed to reveal any association between hearing-aid use and cognitive
status. Additionally, Dawes et al. found no difference between users of hearing aids and nonusers of hearing aids on secondary measures of IADLs, social engagement, and mental health
status (see Table 4). Users of hearing-aids in the Valentijn et al. and Van Hooren et al. studies
also failed to demonstrate any improvement in measures of cognitive status after the follow-up
periods of six years and one year, respectively.
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Table 3
Primary Outcome Measures

Authors

Cognitive
Measures

Follow-up
Period

Results

Acar et al.
(2011)

MMSE

3 months

Allen et al.
(2003)

MMSE

6 months

21
MMSE

25 years

P

Pre

Post

Increase in cognitive function
after HA use

20.38
(3.95)

23.05
(7.59)

<.01

Decrease in cognitive function
as dementia progressed

18.1

16.1

<.01

No HL

Major
HL

26.1
(3.2)

24.1
(5.1)

Model 2 adjusted for age, sex
and education level:
Self-reported HL is
independently associated with
lower MMSE score and greater
cognitive decline over 25 years
as compared to controls.

Amieva et al.
(2016)

Data

<.001
for all
HL

Slope (change in cognitive
function over time)
represented by b
Rate of cognitive decline higher
for those with reported HL who
did not use HA compared to
controls
Rate of cognitive decline in
those with HL using HA not
significantly different from rate
of decline in controls.
Model 3: Adjusted additionally
for depression and social
engagement

b= -0.06

<.001

b=0.07

>.05

Authors

Cognitive
Measures

Follow-up
Period

Results
Rate of cognitive decline in
those with HL and no HA use
not significantly different
compared to controls
Rate of cognitive decline in
those with HL and HA use not
significantly different compared
to controls

Pre

Post

P

b=-0.01

>.05

b=0.05

>.05

HA User
Baseline
26.7
(0.4)
11 Yr
25.9
(0.5)

NonUser
Baseline
26.5
(0.1)
11 Yr
26.9
(0.2)

Test A:
65.0
(7.8)

Test A:
57.5
(2.4)

Test B:
147.5
(14.4)

Test B:
148.3
(4.4)

DSST

26.2
(2.3)

29.2
(0.7)

>.05

AVLT

3.2 (0.5)

4.1 (0.1)

>.05
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MMSE

Dawes et al.
(Nov 2015)

Data

11 years
TMT

No difference in any cognitive
tests between hearing users and
non-users

>.05

>.05

>.05

>.05

Authors

Cognitive
Measures

Follow-up
Period

VFT
Reaction
Time
Dawes et al.
(Mar 2015)

Pairs
Matching

None
(correlational
design)

Fluid
Intelligence

Results

Based on structural equation
modeling, Model 1 indicates
poorer hearing is associated
with poorer cognition.
Model 2 indicates HA use
associated with better cognition

Data
Pre
26.2 (2.3)

Post
29.2 (0.7)

Model 1 Coefficient:
0.11
Model 2 Coefficient:
.004

P
>.05
<.001

<.001

Percent change:
S1=-1%, S2=13%,
S3=14%, S4=7%
S5=9%, S6=17

<.05

CRM

6/6 patients had statistically
significant change in selective
attention as compared with
baseline

Percent Change:
S1=10%, S2=15%,
S3=27%, S4=8%,
S5=12%, S6=19%

<.05
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LST

5/6 patients had statistically
significant change in working
memory as compared with
baseline

Desjardin
(2015)

6 months
Auditory
Reaction Time

2/6 patients had statistically
significant change in processing
speed as compared with baseline

RST

5/6 patients had statistically
significant change in working
memory as compared with
baseline

Percent Change:
S1=-229%,
S2=-65%, S3=-114%, <.05
S4=74%, S5=-164%,
S6=-161%
Percent Change:
S1=10%, S2=-8%,
S3=18%, S4=8%,
S5=13%, S6=10%

<.05

Authors

Cognitive
Measures

Follow-up
Period

Results

Stroop Test
(SCWT)

3/6 patients had statistically
significant change in selective
attention as compared with
baseline

DSST

4/6 patients had statistically
significant change in processing
speed as compared with baseline

Data
Pre
Post
Percent Change:
S1=-5%, S2=5%,
S3=10%, S4=0%,
S5=2%, S6=6%
Percent Change:
S1=3%, S2=12%,
S3=4%, S4=1%,
S5=10%, S6=6%

P

<.05

<.05

VVLT
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SCWT
Valentijn et al.
(2005)

CST

6 years

Change in sensory acuity
(adoption of HA) does not
improve cognitive performance.

VFT
LDST
Baseline
Van Hooren et
al.
(2004)

12 months
SCWT

HA users were
fit at baseline
and utilized

HA use as intervention for
presbyacusis does not improve
cognitive functions
Unexpectedly, performance on

HA:23.4
(6.5)
No HA:
23.2
(5.0)

1 Yr
F/U1
HA:
22.8 (0.3)
<.05
No HA:
21.8 (0.3)

Authors

Cognitive
Measures

CST-I

VVLT

25
LDST

VFT

Follow-up
Period
HA for 12
months

Results

Data

Pre
Post
SCWT decreased after
HA:
HA:
intervention period for both groups
18.29
21.9
(13.8)
(2.0)
No HA:
No HA:
19.04
18.1 (2.3)
(15.6)
HA:
HA:
21.0
25.6 (0.5)
(5.8)
No HA:
No HA:
25.3
20.6
(59)
(4.1)
HA:
26.2
HA:
(6.4)
25.8 (0.4)
No HA:
No HA:
23.4
25.2 (0.5)
(6.8)
HA:
26.5
HA:
(62)
24.9 (0.7)
No HA:
No HA:
25.6
23.6 (0.8)
(7.4)

P

>.05

>.05

>.05

>.05

Table 4
Secondary Outcome Measures
Authors
Acar et al.
(2011)
Allen et al.
(2003)

Other Outcome
Measures
Geriatric
Depression Scale
(GDS)

Results

Data

P

26

Pre

Post

6.8 (4.0)

5.0 (3.5)

<.005

Pt
27.5

Pt
20.7

<.001

Carer
34.3

Carer
21.7

.001

Euro-ADAS

29.1

31.1

>.05

IDDD

66

74

>.05

4

5

<.05

2

3

>.05

The Carer Strain
Scale

4.5

5

>.05

Carer Burden

3

3

>.05

Nursing Home
Hearing Handicap
Index for Patient
and Caretaker
(NHHHIP and
NHHHIC)

The MOUSEPAD
Cornell Scale for
Depression in
Dementia

Decrease in depressive
symptoms

Decrease in handicap for both
patient and caregiver with HA
use

No improvement in cognitive
function, activities of daily
living, depression and
caregiver burden

Authors

Other Outcome
Measures

Results

Dawes et al.
(Nov 2015)
HHIE-S

PCS
ADL
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IADL
Social Engagement
MCS
Dawes et al.
(Mar 2015)

Social Isolation:

HA users reported greater
handicap than non-users

HA users scored better on the
PCS than non-users.
No differences between HA
users and non-users on ADL
and IADL, social engagement
(at 5-year follow up), and
mental health

Data

P

Pre

Post

HA User
Baseline
19.8 (1.0)

Non-User
Baseline
8.3 (0.3)

Baseline
<.0001

11 Yr
22.6 (1.9)

11 Yr
12.4 (0.6)

11 Yr
<.0001

46.2 (2.1)

41.2 (0.7)

<.05

0.7 (0.3)

1.0 (0.1)

>.05

2.5 (0.6)

2.4 (0.2)

>.05

37.9 (2.9)

35.6 (0.9)

>.05

56.7 (1.5)

54.7 (.05)

.05

Model 3 shows social isolation
is associated with poorer
cognition and poorer hearing.

Model 3 Coefficients:
Isolation and Cognition = 0.09
Isolation and Hearing = 0.02

<.001
<.001

Model 4 shows isolation and
poorer hearing associated with
depression and in turn, poorer
cognition. HA use not
associated with depression but
greater isolation and better
cognition.

Model 4 coefficients:
Isolation and Depression = 0.24
Isolation and Hearing = 0.02
Isolation and cognition = 0.09
HA use and depression = 0.0
HA use and isolation = 0.02
HA use and cognition = 0.05

<.001
<.001
<.001
>.05
<.05
<.001

Authors

Other Outcome
Measures

Valentijn et al.
(2005)

Results
Visual Acuity was consistently
more predictive of memory
performance.

Visual acuity

Change in visual acuity
(cataract surgery) also does not
improve cognitive
performance

Data
Pre

Post

P
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DISCUSSION
The purpose of this systematic review is to elucidate the role of hearing-aid use on
cognitive function in adults with hearing loss. That is, can hearing-aid use improve cognitive
function or at least slow down the rate of cognitive decline in adults with hearing loss.
In four studies (Acar et al., 2011; Amieva et al., 2016; Dawes et al., 2015a, Desjardins,
2016), a positive association between amplification and cognitive status was demonstrated and in
one study (Allen et al., 2003), a negative association between amplification and cognitive status
was found. The results of the remaining three studies included in this review are not consistently
supportive of the positive impact of amplification on cognitive status (Dawes et al., 2015b;
Valentijn et al., 2005; Van Hooren et al., 2004).
Of the four studies showing a positive association between amplification and control
status, three (Amieva et al.; 2016; Dawes et al. 2015a; Desjardins, 2015) included control
groups, and two (Amieva et al. and Desjardin) were mixed design studies, incorporating
longitudinal follow-up. Additionally, Desjardins’s treatment group underwent a withdrawal
phase whereby hearing-aid use was discontinued, which resulted in some decrease in cognitive
function; these findings on the effects of withdrawal further support the conclusion that the
observed improvement in cognitive function resulted from use of amplification.
One of the most influential studies that demonstrated amplification benefit on cognitive
status was that by Amieva et al. (2016). Strengths of this study include the 25-year follow-up
period and the fact that it was population-based. Additionally, the study included a control group
of individuals without hearing loss. The coefficient of change that demonstrated reduced rate of
cognitive decline for hearing-aid users remained significant after adjustment for the possible
confounding factors of age, sex, education level, depressive symptomology, and social
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engagement. An additional strength of Desjardin’s (2016) investigation was the battery of
cognitive tests that assessed many facets of cognition.
A limitation, however, of the Amieva et al. (2016) investigation was subjective (selfreport) rather than objective, audiometric assessment of hearing sensitivity. Additionally, hearing
status was assessed only at baseline so the groups may differ on change in hearing status over
time. A major shortcoming of the investigation by Desjardins was the very small sample size (N
= 6). A major limitation of the Acar et al. (2011) study, based on just pre- and post-amplification,
was the absence of a control group. Additionally, Acar et al. did not control for socioeconomic
status, which can influence performance on the MMSE (Tombaugh, 1992).
Only Allen et al. (2003) demonstrated a significant decrease in cognitive function after
use of amplification. The decline, however, was obtained only on the MMSE; no significant
change occurred on other measures of cognition, activities of daily living, depressive symptoms,
or carer burden. Interestingly, Allen et al.’s investigation is the only study that established the
presence of a significant cognitive impairment at baseline. In the other seven studies, the
exclusion criterion for participation included cognitive impairment or cognitive status was not
established at all prior to baseline testing. This recognized cognitive decline at baseline could
have progressed during the six-month follow-up period resulting in poorer MMSE scores
because of the natural course of the disease rather than because of use of amplification.
Dawes et al. (2015b), Valentijn et al. (2005), and Van Hooren et al. (2004) failed to
demonstrate any association between amplification and cognitive status. The strengths of these
studies included being mixed design and having large sample sizes (N = 102 to 666).
Additionally, Dawes et al. (2015b) employed a long (11-year) follow-up period and a battery of
cognitive tests. Dawes et al. speculated that their investigation lacked sufficient statistical power
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necessary to detect small differences in cognitive status between groups. They contended that
their study had sufficient statistical power to detect a medium effect size that would be adequate
to observe a clinically significant change on outcome measures. Consistency of hearing-aid use,
however, over the 11-year follow-up period could not be established. Similarly, although
Valentijn et al. (2005) also had a long follow-up period with a comprehensive cognitive test
battery, their study lacked statistical power as only 7 of the 391 participants were hearing-aid
users.
The third study that failed to demonstrate any significant association between
amplification and cognition was that by Van Hooren et al. (2004). One explanation for these
results is that the follow-up period of one year was insufficient to detect a cognitive change.
An additional shortcoming in Acar et al. (2011), Allen et al. (2003), Amieva et al. (2016),
and Dawes et al. (2015b) studies employing the MMSE was the failure to ensure that the
participants with hearing loss could hear the orally administered MMSE. Thus, poor performance
on the MMSE could have at least partially resulted from lack of audibility during test
administration. According to Jorgensen et al. (2016), reduced audibility can result in a greater
apparent cognitive decline even when a cognitive decline is not actually present. Only Dawes et
al.’s (2015b) study did not suffer from this limitation as they administered the test as a computerbased test rather than orally.
A shortcoming of all the investigations was the lack of random assignment of participants
into the control and experimental groups. However, this threat to internal validity cannot be
avoided as it would be unethical to randomly assign an individual to the control group, thereby
preventing them from using amplification, particularly for long periods of time. The negative
effects of auditory deprivation as it relates to degraded speech perception (Silman et al., 1984)
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and cross-modal cortical reorganization (Glick & Sharma, 2017) have been established. As a
result, long-term longitudinal studies of the effects of amplification on cognitive status will likely
always be observational in nature.
Future research should investigate the role that amplification plays in mild cognitive
impairment in adults with hearing loss. Mild cognitive impairment differs from dementia
disorders in that those with the former condition have intact ability to carry out IADLs (Winblad,
2004). Nevertheless, mild cognitive impairment in older adults can degenerate to a probable
Alzheimer’s disease at a rate of 10-15% per year as compared with normal older adults who
develop the disease at a rate of 1-2% per year (Petersen, 2002). Those with mild cognitive
impairment are an at-risk population to develop a more significant cognitive disorder, similar to
older adults with hearing loss, as reported in several studies described in this systematic review.
As no pharmacological interventions exist that conclusively prevent the progression from mild
cognitive impairment to dementia, establishing a positive association between amplification and
mild cognitive impairment could provide an intervention method early on in the disease
progression. Audiologists should continue to play a role in mitigation of cognitive decline by
effectively screening for mild cognitive impairment, using measures such as the MoCA and
Qmci (O’Caoimh et al., 2016), and by recommending hearing aids to adults with hearing loss
identified by these screeners.
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CONCLUSIONS
The findings of these eight studies reviewed all contribute to the body of knowledge that
exists on how hearing loss, amplification, and cognition interact. Although the studies do not
overwhelmingly support the use of amplification as an intervention method for cognitive decline
in adults with hearing loss, the existing evidence does not suggest that the use of amplification
could be detrimental to cognition. Use of hearing aids can improve overall quality of life and can
promote healthy aging; it may also have positive impact on cognition. Therefore, hearing aids
should continue to be recommended by audiologists and other health-care professionals who see
adults with hearing loss.
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